Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jake Reder
Institution:
Celdara Medical (United States)
Observed institution:
Celdara Medical (United States)
ORCID:
0000-0002-7975-9874
Observed ORCID:
0000-0002-7975-9874
OpenAlex ID:
A5031976037
Works
19
Awards
3
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2018
·
Susanne H. Baumeister
, Joana Murad
, et al.
·
Cancer Immunology Research
·
350
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice
2016
·
Marie-Louise Sentman
, Joana M Murad
, et al.
·
The Journal of Immunology
·
63
Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy
2018
·
Joana M. Murad
, Susanne H. Baumeister
, et al.
·
Cytotherapy
·
53
Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma
2016
·
Sarah Nikiforow
, Lillian Werner
, et al.
·
Blood
·
44
Targeting of intragraft reactive oxygen species by APP-103, a novel polymer product, mitigates ischemia/reperfusion injury and promotes the survival of renal transplants
2020
·
Koichiro Minami
, Soochan Bae
, et al.
·
American Journal of Transplantation
·
38
A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma.
2016
·
Sarah Nikiforow
, Joana Murad
, et al.
·
Journal of Clinical Oncology
·
31
Conductive Tracks and Passive Electronics
2012
·
Jake Reder
·
Wiley eBooks
·
4
The Polymer Pro-Drug APP-103 Mitigates I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model
2018
·
Koichiro Minami
, Hirofumi Uehara
, et al.
·
Transplantation
·
1
Programmable regulatory T cell platform for control of neuroinflammatory diseases 2310203
2026
·
Colleen Doyle Cooper
, Joana Murad Mabaera
, et al.
·
The Journal of Immunology
PDF
Pharmacological administration of anti-oxidative APP-103 protects the acute kidney injury by regulating the mitochondrial function and ferroptosis
2025
·
Xiaoxin Wang
, Komuraiah Myakala
, et al.
·
Physiology
Table S3 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
Table S2 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
Table S1 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
Figure S1 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
Data from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
Figure S1 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
Table S3 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
2023
·
Susanne H. Baumeister
, Joana Murad
, et al.
App-103, a Novel Polymer Ameliorates Ischemia-reperfusion Injury and Prolongs Transplant Survival
2020
·
Koichiro Minami
, Soochan Bae
, et al.
·
Transplantation
Pd25-08 the Polymer Pro-drug App-103 Mitigates I/r Injury and Improves Graft Function in a Pre-clinical Renal Transplant Model
2018
·
Koichiro Minami
, Abdallah Elkhal
, et al.
·
The Journal of Urology
PDF
Show more works
View as search
Works count:
19
Citation count:
584
H-index:
6
I10-index:
6
Year
Topic
Type